Edmonton, AB - Sulfonylureas -- the mainstay of glucose control in type 2 diabetes -- increase the risk of both cardiovascular and all-cause mortality, a new study has found [ 1]. The retrospective ...

For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, a new ...

Type 2 diabetes medications offer many options to help manage your blood sugar (also known as blood glucose) and your condition. But sometimes a medication doesn’t get the job done, causes bothersome ...

Many medications can help increase your body’s insulin production. These may include amylin mimetics, incretin mimetics, dipeptidyl-peptidase 4 inhibitors, sulfonylureas, linides, and more. Insulin is ...

THE advances in biochemistry of the past decade have revealed that the defects in carbohydrate metabolism in diabetes involve several distinct areas in hepatic metabolism, together with a defect in ...

Sulfonylurea drugs, such as glibenclamide, are widely used for the treatment of type 2 diabetes. These drugs work by causing pancreatic beta cells to release insulin, which occurs when the drug ...

The subjects of the study were 228 diabetic children, 104 boys and 124 girls. All were under sixteen years of age. With few exceptions, all were in summer camps for diabetic children and leading ...

PHILADELPHIA—Initiating treatment of type 2 diabetes with sulfonylurea drugs is associated with an increased risk of renal function decline, end-stage renal disease (ESRD), or death compared with ...

For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds ...